[1]
N. P. Murray, “Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study”, Urol J, vol. 17, no. 3, pp. 262–270, May 2020.